and small mutations of HNF1B are all associated with the RCAD phenotype [Heidet et al., 2010] . Mefford et al. [2007] identified a recurrent 1.5-Mb de novo deletion in 17q12 encompassing the HNF1B gene that results in phenotypes ranging from congenital renal abnormalities to MODY type 5. Variable expressivity of renal disease and diabetes has been noted in many families with this condition and affected individuals may also have abnormalities of the genital tract. Only 2 of 19 cases have shown parental transmission, and in each of these cases, the parent and affected offspring exhibited a similar phenotype.
was within the 'low average range' of intellectual function (19th percentile) as measured by Full scale IQ derived from the 10 subtest scores on the Wechsler Intelligence Scale for Children (Australia) -4th edition. Function may have been significantly affected by social stressors and improvements were observed on stimulant medication and placement with an alternative caregiver. Family history of learning problems prompted referral to a clinical genetics service for evaluation. No renal tract abnormalities were noted on ultrasound.
She has 1 sibling, a 2.5-year-old male with mild developmental delay and bilateral renal cystic disease. An antenatal ultrasound scan at 30 weeks of gestation showed that 1 kidney was larger than the other. A 5-day postnatal scan revealed multiple cysts in both kidneys. Repeat ultrasound at 9 months of age revealed echogenic kidneys with multiple small bilateral renal cysts thought to represent cystic dysplasia. Infantile presentation of autosomal dominant polycystic kidney disease was also considered but thought less likely. His growth was normal, weight 12.7 kg (50th percentile), height 82.2 cm (25th percentile), and no detail on head circumference was given. He had isolated mild gross motor delay achieving sitting at 9 months of age.
The proband's father had significant learning difficulties as a child and is unable to read or write. He has 1 brother with low normal intelligence who stutters, and his mother has learning difficulties, too. The proband's mother has learning difficulties of a lesser degree compared to the father and is able to read and write, but she is adopted and there is very little known about her extended family history. Both parents were in special needs classes at school and have never been in employment. No behavioral issues were noted in either of them. There is no known extended family history of renal disease or early onset diabetes in either family. Both parents have had normal renal ultrasounds, random blood glucose and hemoglobin A1c (HbA 1c ) results.
Materials and Methods
A DNA sample was initially obtained from the 7-year-old proband for genome-wide copy number analysis using the Affymetrix Cytogenetics Whole-genome 2.7M array, according to manufacturer's instructions. Regions of copy number variation (CNV) were identified using the Affymetrix Chromosome Analysis Suite software (ChAS) v.1.0.1 and interpreted with the aid of UCSC genome browser (http://gemome.ucsc.edu/; Human Mar. 2006 (hg18) assembly). The male sibling and both parents were subsequently tested using the same methodology.
Results
The array analysis of the proband revealed a 1.4-Mb heterozygous deletion involving interstitial chromosome region 17q12 (coordinates of the deleted region chr17: 31,923,035-33,323,544; fig. 1 ). The deletion was also detected in the male sibling, thereby conferring an obligate carrier status on one of the parents. The array result for the father of our proband revealed no CNVs, while the mother carried a sole CNV that corresponded to the same 17q12 deletion as her affected son and daughter. The deletion is likely to be caused by nonallelic homologous recombination involving nonrepetitive sequences with a high (at least 90%) level of homology ( fig. 1 ).
Discussion
The 17q12 deletion phenotype comprises some, all or none of the following features: renal abnormalities including cysts; genital tract anomalies; MODY type 5 diabetes mellitus; mild dysmorphic features; and developmental delay with or without behavioral problems. The majority of cases of RCAD caused by mutation or deletion of the HNF1B gene reported in the literature are intellectually normal with renal disease and/or MODY. In contrast, multiple members of the family in our case report exhibited developmental delay, behavioral issues and learning difficulties.
One case with a de novo 17q12 microdeletion and genital anomalies has been described who had severe learning disability and seizures, without diabetes or renal malformations [Cheroki et al., 2008] . An investigation of a cohort of 53 children with renal cysts and deletion of the entire HNF1B gene revealed 3 to carry a de novo deletion; these 3 children showed early onset developmental delay and social interaction impairments concordant with autism [Loirat et al., 2010] . Of 4 further patients who were investigated due to renal disease, 3 exhibited developmental delay; parental studies were only available for 1 case, which confirmed a de novo deletion [Nagamani et al., 2010] . Studies by Moreno-De-Luca et al. [2010] of individuals affected with neurodevelopmental disorders identified 18 patients with a recurring 1.4-Mb deletion of 17q12; parental information was available for 8 patients, one of which had a maternally inherited deletion. The mother was affected with bipolar disorder, diabetes and kidney cysts. Ascertainment bias should be taken into consideration where the studies targeted specific groups, namely those patients with renal cysts [Cheroki et al., 2008] or neurodevelopmental disorders [Moreno-De-Luca et al., 2010] . Analysis of several large populations indicated a statistically significant risk of associated neurodevelopmental disorders and RCAD [Moreno-De-Luca et al., 2010] . Detailed patient information is available on 26 patients from 5 earlier studies [Mefford et al., 2007; Bernardini et al., 2009; Loirat et al., 2010; Moreno-De-Luca et al., 2010; Nagamani et al., 2010] . Features in common were genitourinary tract anomalies including renal cysts, mild to moder-ate neurocognitive delay mainly affecting speech, and several cases of macrocephaly or mild dysmorphic features. Our family shared the neurocognitive delay but had no dysmorphic features or macrocephaly of note and only 1 out of the 3 family members had renal cysts.
There are multiple confounding factors in our family that make it difficult to assign a strong association between the microdeletion and learning delay. The father had intellectual impairment without carrying the deletion. In addition, the absence of a family history in the mother who carries the microdeletion makes interpretation of the cause of her learning problems difficult.
Of the 15 genes localized to the 17q12 microdeletion region, 2 may play a role in the variable phenotypes seen in affected carriers. Expression of the HNF1B gene is associated with vertebrate hindbrain development [Chomette et al., 2006; Pouilhe et al., 2007] and the translation product of this gene, hepatocyte nuclear factor-1, guides the embryological development of the kidneys, pancreas, liver and Müllerian ducts [Bingham and Hattersley, 2004] . LHX1 is a candidate gene for the learning difficulties. Animal models have shown this gene to be an essential regulator of the vertebrate head organizer and to be also expressed in the developing kidney [Shawlot and Behringer, 1995] . Expression of the mouse Lhx1 gene has also been shown to be involved in the developmental processes of the genitourinary system, including the Mülle-rian ducts [Kobayashi et al., 2005] . It is required for migration of motor axons to the limb [Kania et al., 2000] , may be involved in Purkinje cell development in the cerebellum [Zhao et al., 2007] , and knockout mice exhibit anencephaly [Shawlot and Behringer, 1995] . Linkage studies of autism have identified a susceptibility locus in 17q11-17q21 [Kumar and Christian, 2009] .
As with both monogenic and contiguous gene disorders, the 17q12 deletion genotype:phenotype correlation is highly variable. This variation in phenotype is suggestive of incomplete penetrance and variable expressivity, which is seen in our case. Several monogenic diseases including Bardet-Biedl syndrome (OMIM 209900) [Katsanis, 2004] and nephronopthisis (OMIM 25610) [Hoefele et al., 2007] are oligogenic where multiple rare variants interact genetically to modify or cause disease expression [Sykiotis et al., 2010] . Contiguous gene disorders such as the 16p11.2 dele- tion syndrome (OMIM 611913) also show considerable variability [Ballif et al., 2007] , with a 'second hit' possibly affecting severity. Girirajan et al. [2010] suggest that this could be another CNV, a small disruptive mutation in a related gene, an environmental event leading to alteration in gene dosage, or the creation of a fusion gene. This 2-hit scenario may also explain the comorbidity which exists between cognitive impairment, autism and schizophrenia, in addition to the previously mentioned variation associated with microdeletion/duplication syndromes [Fombonne, 2002; Sharp et al., 2008; Woodberry et al., 2008] .
Our case illustrates the unlikely probability of the modifier being a second CNV. There were no additional CNV calls in any of the family members, which strongly suggests a modifier of unknown origin as previously reported in thrombocytopenia-absent radius syndrome (OMIM 274000) [Klopocki et al., 2007] . There may be a smaller CNV occurring elsewhere in the genome, below the resolution detected by Affymetrix arrays, and conferring a transcription-related, neurodevelopmental or receptor function that exacerbates the effect of the 17q12 deletion in the offspring [Nord et al., 2011] . Alternatively, there may be a relatively common variant or polymorphism which acts as trigger.
Despite the points mentioned above, the variation in severity of the disease warrants the close surveillance of deletion carriers; the renal disease can range from asymptomatic to requiring transplant or dialysis dependence [Edghill et al., 2008] . The MODY type 5 diabetes mellitus is an autosomal dominant form of nonketotic diabetes mellitus with a typical onset of 25 years of age. The carrier mother is now 27 years old and should be carefully monitored.
